all - Opinion Summaries
Page 10 of 88
Showing Result 91 - 100 of 874
| Description | Date | Docket # |
|---|---|---|
Merck & Cie v. Watson Labs., Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn a case alleging infringement when defendant filed an Abbreviated New Drug Application (ANDA) seeking approval to manufacture and market generic... |
05/13/2016 | 2015-2063, 2015-2064 |
Eisai Inc v. Sanofi Aventis U.S. LLCUnited States Third Circuit
Drugs & Biotech, Antitrust & Trade RegulationIn an antitrust suit alleging the conduct of defendant harmed competition in the market for anticoagulant drugs by preventing hospitals from replacing... |
05/04/2016 | 14-2017 |
In re Pfizer Inc. Sec. Litig.United States Second Circuit
Class Actions, Securities Law, Evidence, Drugs & BiotechIn a securities class action, contending that Pfizer made fraudulent misrepresentations and omissions regarding the safety of Celebrex and Bextra in... |
04/12/2016 | 14-2853-cv |
Animal Legal Def. Fund v. FDAUnited States Ninth Circuit
Drugs & Biotech, Government LawIn a Freedom of Information Act (FOIA) case, challenging the FDA's decision to redact certain commercially-sensitive information concerning... |
04/11/2016 | 13-17131 |
Genetic Technologies Ltd. v. Merial L.L.C.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an infringement suit involving a patent which relates to methods of detecting genetic variations, the district court's grant of defendants' motions... |
04/08/2016 | 2015-1202, 2015-1203 |
Union of Med. Marijuana Patients, Inc. v. City of UplandCalifornia Court of Appeal
Environmental Law, Drugs & BiotechIn a civil action, a denial of plaintiff's petition for writ of mandate to set aside an ordinance prohibiting mobile medical marijuana dispensaries... |
03/25/2016 | D069293 |
Belmora v. Bayer Consumer Care AGUnited States Fourth Circuit
Intellectual Property, False Advertising, Trademark, Drugs & Biotech, International LawIn an international trademark action between two companies selling naproxen sodium pain relievers in Mexico under the name FLANAX, plaintiff Belmora... |
03/23/2016 | 15-1335 |
Acorda Therapeutics Inc. v. Mylan Pharms. Inc.United States Federal Circuit
Civil Procedure, Intellectual Property, Patent, Drugs & BiotechIn an appeal involving two separate actions brought under 35 U.S.C. section 271(e)(2) in the District of Delaware against generic drug manufacturer... |
03/18/2016 | 2015-1456 |
T.H v. Novartis PharmaceuticalsCalifornia Court of Appeal
Injury & Tort Law, Drugs & Biotech, Product LiabilityIn a action alleging a former manufacturer of a brand-name asthma medication is liable in negligence for neurological injuries allegedly sustained by... |
03/09/2016 | D067839 |
In Re: Loestrin 24 FE Antitrust LitigationUnited States First Circuit
Class Actions, Drugs & BiotechIn consolidated pharmaceutical antitrust appeals involving an oral contraceptive drug Loestrin 24, alleging that settlement agreements between... |
02/22/2016 | 14-2071, 15-1250 |
Results 91 to 100 of 874